Implanted Defibrillators in Young Hypertrophic Cardiomyopathy Patients: A Multicenter Study

• Published in: Pediatric cardiology Vol. 34; no. 7; pp. 1620 - 1627
• Main Authors: Kamp, Anna N., Von Bergen, Nicholas H., Henrikson, Charles A., Makhoul, Majd, Saarel, Elizabeth V., LaPage, Martin J., Russell, Mark W., Strieper, Margaret, Yu, Sunkyung, Dick, Macdonald, Day, Sharlene M., Bradley, David J.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.10.2013; Springer
• Subjects: Cardiac Surgery; Cardiology; Cardiomyopathy, Hypertrophic; Cardiomyopathy, Hypertrophic - mortality; Cardiomyopathy, Hypertrophic - therapy; Cardiovascular diseases; Child; Child, Preschool; Death, Sudden, Cardiac - epidemiology; Death, Sudden, Cardiac - prevention & control; Defibrillators; Defibrillators, Implantable; Female; Follow-Up Studies; Health aspects; Heart; Humans; Incidence; Infant; Infant, Newborn; Male; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Original Article; Prevention; Primary Prevention - methods; Retrospective Studies; Risk Assessment - methods; Risk factors; Survival Rate - trends; Time Factors; Treatment Outcome; United States - epidemiology; Vascular Surgery; United States; Hypertrophic cardiomyopathy; Implantable cardioverter-defibrillator; Pediatric; Young adult

Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease, with an annual risk of sudden cardiac death (SCD) estimated at 1 %. Limited data are available regarding both the risk of SCD in the young HCM population and the use of implantable cardioverter-defibrillators (ICDs)...